Indian employees of the Ranbaxy Laboratories Limited pharmaceutical Indian factory leave work at the end of the day at Toansa village in Ropar about 50 Km from Chandigarh on May 14, 2013. The US subsidiary of New Delhi-based Ranbaxy Laboratories pleaded guilty to seven counts of felony after it distributed several India-produced adulterated generic drugs in the United States in 2005 and 2006. They were all made in a facility near Chandigarh city in northern India, which US Food and Drug Administration inspectors cited for poor record keeping and inadequate testing for the stability of the drugs over time.
A view of the Ranbaxy Laboratories Limited pharmaceutical Indian factory at Toansa village in Ropar about 50 Km from Chandigarh on May 14, 2013. The US subsidiary of New Delhi-based Ranbaxy Laboratories pleaded guilty to seven counts of felony after it distributed several India-produced adulterated generic drugs in the United States in 2005 and 2006. They were all made in a facility near Chandigarh city in northern India, which US Food and Drug Administration inspectors cited for poor record keeping and inadequate testing for the stability of the drugs over time.
Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration (FDA), speaks during the 2013 Reuters Health Summit in New York, May 6, 2013.
This product image provided by the Wm. Wrigley Jr. Company shows packaging for Alert Energy Caffeine Gum. Wrigley says it is taking a new caffeinated gum off the market temporarily as the Food and Drug Administration investigates the safety of added caffeine. The company said Wednesday, May 8, 2013, that it has stopped new sales and marketing of Alert Energy Caffeine Gum "out of respect" for the agency, which said it would investigate the health effects of added caffeine in foods just as Wrigley rolled out Alert late last month. A stick of the gum is equivalent to half a cup of coffee.
Importers and supporters offers samples of French cheese Mimolette to pedestrians during an event to support the import in the US of the 17th century-old cheese, after the US Food and Drug Administration (FDA) blocked the cheese to enter the territory, during an event in New York, April 13, 2013. The FDA, blocked the import of Mimolette on the ground that the cheese was infested with microscopic cheese mites on the surface, which can cause allergic reactions.
Health and Human Services (HHS) Secretary Kathleen Sebelius, center, accompanied by Centers for Medicare and Medicaid Services Acting Administrator Marilyn Tavenner, left, and Food and Drug Administration (FDA) Commissioner Margaret Hamburg, speaks during a news conference at the HHS in Washington, Wednesday, April 10, 2013, to discuss President Barack Obama's fiscal 2014 for the Health Department.
